REFERENCES
- Bakhaeva, G. P., Berlin, Y. A., Boldyreva, E. F., Chuprunova, O. A., Kolosov, M. N., Soifer, V. S., Vasiljeva, T. E. & Yartseva, I. V. 1968. The structure of aureolic acid (Mithramycin). Tetrahedron Lett 32, 3595–3598.
- Brown, J. H. & Kennedy, B. J. 1965. Mithramycin in the treatment of disseminated testicular neoplasm. N Engl J Med 272, 111–118.
- Currerie, A. F. & Ansfield, F. J. 1960. Mithramycin—human toxicology and preliminary therapeutic investigation. Cancer Chemother Rep 8, 18–22.
- Ekman, H., Giertz, G., Jönsson, G. & Notter, G. 1965. Tumors of the testicle: a report from Sweden on combined surgico-radiotherapeutic treatment. XIII Congrès Soc Internat d'Urol II, 26–62.
- Ingemansson, S., Henriksson, H. & Ling, L. 1972. Lymfadenectomi vid testistumörer. In Sammanfattningar av symposier och föredrag, XXIX Medicinska Riksstämman, Svenska Läkarsällskapet. Stockholm.
- Javadpour, N., Thomas, W. & Burke, J. M. 1971. Production and treatment of testicular teratocarcinoma induced by genital ridge transplantation. J Urol 105, 534–539.
- Johnson, D. E. & Luce, J. K. 1972. In Testicular Tumors (ed. D. E.Johnson), Chap. 9. p. 231. Huber; Bern, Stuttgart and Vienna.
- Kennedy, B. J., Yarbro, J. W., Kickertz, V. & Sandberg-Wollheim, M. 1968. Effect of Mithramycin on mouse glioma. Cancer Res 28, 91–97.
- Kennedy, B. J. 1970. Mithramycin therapy in advanced testicular neoplasms. Cancer 26, 755–766.
- Kofmann, S. & Eisenstein, R. 1963. Mithramycin in the treatment of disseminated cancer. Cancer Chemother Rep 32, 77–96.
- Koons, C. R., Sensenbrenner, L. L. & Owens, A. H., Jr. 1966. Clinical studies of Mithramycin in patients with embryonal cancer. Bull Johns Hopk Hosp 118, 462–475.
- Li, M. C., Whitmore, W. F., Jr., Golbey, R. & Grabstad, H. 1960. Effects of combined drug therapy on metabolic cancer of the testis. JAMA 174, 1291–1299.
- MacKenzie, A. R., Duruman, N. & Whitmore, W. F., Jr. 1967. Mithramycin in metastatic urogenital cancer. J Urol 98, 116–117.
- Monto, R. W., Talley, R. W., Caldwell, M. J., Levin, W. E. & Guest, M. M. 1969. Observations on the mechanism of haemorrhagic toxicity in Mithramycin (NSC 24559) therapy. Cancer Res 29, 697–700.
- Mount, B. M., Stevens, L. C. & Whitmore, W. F., Jr. 1970. The effect of chemotherapy on germinal testicular tumors in mice. Cancer 26, 570–576.
- Parker, G. W., Wittsie, D. S. & Jackson, C. B., Jr. 1960. The clinical evaluation of PA-144 (Mithramycin) in solid tumors of adults. Cancer Chemother Rep 8, 23–26.
- Rao, K. V., Cullen, W. P. & Sobin, B. A. 1960. Mithramycin: antibiotic with antitumor properties. Proc Amer Ass Cancer Res 3, 143.
- Ream, N. W., Perlia, C. P., Wolter, J. & Taylor, S. G., III. 1968. Mithramycin therapy in disseminated germinal testicular cancer. JAMA 204, 96–102.
- Stevens, L. C. 1964. Experimental production of testicular teratomas in mice. Proc Nat Acad Sci USA 52, 654–661.